[22] Diabetes Epidemiology Research International (DERI) Mortality Study Group: International evaluation of cause-specific mortality and IDDM. Diabetes Care 1990; 14: 55-60.
[23] Portuese E, Orchard T. Mortality in insulin-dependent diabetes mellitus. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, editors. Diabetes in America, 2nd ed, Bethesda. Md: National Institutes of Diabetes and Digestive and Kidney Diseases; 1995: 221-32. NIH publication no. 95-1468.
[24] Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E, and the WHO Multinational Study Group. Proteinuria and mortality in diabetes: the WHO multinational study of vascular disease in diabetes. Diabet Med 1995; 12: 149-55.
[25] Centers for Disease Control. Diabetes surveillance 1993. Atlanta, Ga: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1993.
[26] Tattersall RB, Gale EAM, Mortality. In: Frier BM, Fisher BM, editors. Hypoglycaemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993.
[27] Zimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDM: lessons from the South Pacific. Diabet Metab Rev 1990; 6: 91-124.
[28] Bennet PH, Bogardus C, Tuomilehto J, Zimmet P. Epidemiology and natural history of NIDDM: non-obese and obese. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, editors. International textbook of diabetes mellitus. Chichester: John Wiley and Sons Ltd; 1992: 147-76.
[29] Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-31.
[30] Groeneveld Y, Petri H, Hermanst J, Springer MD. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med 1999; 16: 2-13.
[31] Bain SC, Mijovic CH, Barnett AH. Genetic factors in the pathogenesis of insulin-dependent diabetes mellitus. In: Pickup J, Williams G, editors. Textbook of diabetes. Oxford: Blackwell Science: 1997: 13.1-13.13.
[32] Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5: 601-4.
[33] Levy-Marchal C, Patterson C, Green A. on behalf of the EURODIAB ACE Study Croup. Variation by age group and seasonality at diagnosis of childhood type 1 diabetes In Europe. Diabetologia 1995; 38: 823-30.
[34] Wasmuth HE, Kolb H. Cow's milk and immune-mediated diabetes. Proc Nutr Soc 2000; 59: 573-9.
[35] Ginsberg-Fellner F, Fedun B, Cooper Z, et al. Interrelationships of congenital rubella and type 1 insulin-dependent diabetes mellitus. In: Jaworski MA, Molnar CD, Rajotte RV, Singh B, editors. The immunology of diabetes mellitus. Amsterdam: Elsevier; 1986: 279-86.
[36] Rabinovitch A. Immune regulatory and cytokine imbalance in the pathogenesis of IDDM. Diabetes 1994; 43: 613-21.
[37] Liblau RS, Singer SM, McDevitt HO. Th1 andTh2CD4+Tcells in the pathogenesis of organ-specific autoimmune disease. Immunol Today 1995; 16: 34-8.
[38] Kolb H. Benign versus destructive insulitis. Diabetes Metab Rev 1997; 13: 139-46.
[39] Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of patients with type 1 diabetes: the 2 year analysis of the German BABYDIAB Study. Diabetes 1999; 48: 460-8.
[40] Katz JD, Benoist C, Mathis D.T helper cell subjects in insulin-dependent diabetes. Science 1995; 268: 1185-8.
[41] Healey D, Ozegbe P, Arden S, Chandler P, Hutton J, Cooke A. In vitro activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 1995; 95: 2979-85.
[42] Kallmann B, Hüther M, Tuber M, Feldkamp J, Bertrams J, Gries FA, Lampeter EF, Kolb H. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves disease. Diabetes 1997; 46: 237-43.
[43] Martin S, Kolb H. Type 1 Diabetes: Immunopathogenese, Immunintervention und Immunprävention. In: Schatz H, editors. Diabetologie kompact. Berlin: Blackwell, 2001:45-52.
[44] Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson F, Chase HP, Eisenbarth GS. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA 512 bdc/IA-2 antibodies. Diabetes 1996; 45: 926-33.
[45] McKeigue PM. Ethnic variation in insulin resistance and risk of type 2 diabetes. In: Reaven G, Laws S, editors. Contemporary endocrinology: insulin resistance. Totowa, NJ: Humana Press Inc; 1999: 19-33.
[46] Vadheim CM, Rotter JI. Genetics of diabetes mellitus. In: Alberti KGMM, DeFronzo R, Keen H, Zimmet P, editors. International textbook of diabetes mellitus. Chichester: John Wiley & Sons; 1992: 31-98.
[47] Neel JV. Diabetes mellitus: a thrifty genotype rendered detrimental by “progress”. Am J Hum Genet 1962; 14: 353-62.
[48] Dowse G, Zimmet P. The thrifty genotype in non-insulin-dependent diabetes. BMJ 1993; 306: 532-3.
[49] Pfeiffer AFH. Die verschiedenen Formen der Zuckerkrankheit und deren Genetik. In: Schatz H, editor. Diabetologie kompakt. Berlin: Blackwell, 2001: 5-13.
[50] Jahnke K, Daweke H, Liebermeister H, Schilling WH, Thamer G, Preiss H, Gries FA. Hormonal and metabolic aspects of obesity in humans. In: Östmann J, editor, Diabetes. Proceedings of the sixth congress of the International Diabetes Federation. Amsterdam: Exerpta Medica Foundation: 1969: 533-9.
[51] Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. I: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.
[52] Poulsen P, Vaag A, Kyvik K, Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 2001; 44: 537-43.
[53] Manson JE, Rimm EB, Stampfer MJ, Colditz JA, Willett WC, Krolewski AS, Rossner B, Hennekens CH, Speizer FE. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991; 338: 774-8.
[54] Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Colditz GA, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268: 63-7.
[55] Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willet WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-9.
[56] Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122:481-6.
[57] Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-7.
[58] Björntorp P. Abdominal obesity and the development of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1988; 4: 615-22.
[59] Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811.
[60] Kohrt WM, Kirvan JP, Staten MA, Bourey RE, King DS, Holloszy JO. Insulin resistance in aging is related to abdominal obesity. Diabetes 1993; 42: 273-81.
[61] Matsuzawa Y, Shimomura J, Nakamura T, Keno Y, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. In: Sakamoto N, Alberti KCMM, Hotta N, editors. Pathogenesis and treatment of NIDDM and its related problems. Amsterdam. Exerpta Medica, Int Congr Series 1057; 1994: 171.
[62] Lean MEJ, Powrie JK, Anderson